Eyal Shoshani joined Gamida Cell as Vice President, Clinical Operations in October 2021, bringing close to 20 years of experience in clinical development and trial management. Before joining Gamida Cell, Eyal was Head of Clinical Operations at Minovia Therapeutics, where he led a team responsible for clinical trials using hematopoietic stem-cell-derived therapies for children with a rare mitochondrial disease. Prior to Minovia, Eyal held clinical operations roles of increasing responsibility at Pluristem and Dexcel Pharma. Eyal began his career as a clinical research associate at Bypass Ltd and Quintiles (now IQVIA). Eyal earned a B.Sc. In Biotechnology Engineering at Ben Gurion University in Beer Sheva and an M.B.A. at the Open University in Israel.